Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Granisetron Nasal Spray in Healthy Volunteers
NCT02563951Phase 1Completed
- Sponsor
- Maxinase Life Sciences
- Start
- Sep 2015
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Granisetron Hydrochloride Nasal Spray in chemotherapy-induced nausea and vomiting (CINV) (5 arms), sponsored by Maxinase Life Sciences. Primary endpoints: Area under the plasma concentration-time curve from zero to infinity, Area under the plasma concentration-time curve from zero to last quantifiable concentration and 1 more. Started Sep 2015; status: completed.
02
Drugs
Granisetron Hydrochloride Nasal Spray
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT02563951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02563951.